Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001209191-22-055138

Chief Scientific Officer sold 1,165 shares at $12.88 ($15,006)

  • Chief Scientific Officer acquired 3,207 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hansen Gwenn · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-10-30 Exercise or conversion : show line 1 in the form +3,207 22,379 D
2022-10-31 Sale : show line 2 in the form −1,165 $12.88 $15,006 21,214 D
Open-market sales · 1,165 sh · avg $12.88 · $15,006

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-10-30 Exercise or conversion : show line 3 in the form Restricted Stock Units −3,207 41,688 D
Loading xslF345X03/doc4.xml…